Status:
RECRUITING
Derivation of New Human Embryonic Stem Cell Lines Lines for Clinical Use
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Infertility
Eligibility:
All Genders
18+ years
Brief Summary
Human embryonic stem cells (hESCs) are isolated from the early human embryo and have the capability to proliferate indefinitely in culture and to develop into nearly every cell of the human body. Ther...
Detailed Description
Embryonic stem (ES) cell lines are derived from the pluripotent cells of the early embryo. The key properties of ES cells are their ability to proliferate indefinitely in vitro without differentiation...
Eligibility Criteria
Inclusion
- Couple has embryos derived through IVF that they wish to donate to research.
- Couple has finished building their family.
- Couple has them stored in liquid nitrogen for \> or = to 5 years.
- Couple will submit to an interview, blood tests, and physical exam by a physician.
- Couple will give informed consent and will consent to have their medical history examined by the research group.
Exclusion
- Couple has not finished building their family.
- Couple has embryos but they have not been stored for \> or = to 5 years.
- Couple will not submit to an interview, blood tests, or physical exam by a physician.
- Couple refuse to give informed consent, or will not consent to have their medical history examined by the research group.
- Couple has spent an extended period of time in exclusion countries (HIV or vCJD risk).
- Couple tests positive for exclusion viruses (as listed in the Informed Consent).
Key Trial Info
Start Date :
July 7 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00353197
Start Date
July 7 2002
End Date
December 1 2030
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, 91120